Literature DB >> 34758300

Acsbg1-dependent mitochondrial fitness is a metabolic checkpoint for tissue Treg cell homeostasis.

Toshio Kanno1, Takahiro Nakajima1, Yusuke Kawashima2, Satoru Yokoyama1, Hikari K Asou1, Shigemi Sasamoto1, Koji Hayashizaki3, Yuki Kinjo3, Osamu Ohara2, Toshinori Nakayama4, Yusuke Endo5.   

Abstract

Regulatory T (Treg) cells are critical for immunological tolerance and immune homeostasis. Treg cells strongly rely on mitochondrial metabolism and show a lower level of glycolysis. However, little is known about the role of lipid metabolism in the regulation of Treg cell homeostasis. Some members of the ACSL family of acyl-coenzyme A (CoA) synthases are expressed in T cells, but their function remains unclear. A combination of RNA-sequencing and proteome analyses shows that Acsbg1, a member of ACSL, is selectively expressed in Treg cells. We show that the genetic deletion of Acsbg1 not only causes mitochondrial dysfunction, but it also dampens other metabolic pathways. The extrinsic supplementation of Acsbg1-deficient Treg cells with oleoyl-CoA restores the phenotype of the Treg metabolic signature. Furthermore, this pathway in ST2+ effector Treg cells enhances immunosuppressive capacity in airway inflammation. Thus, Acsbg1 serves as a metabolic checkpoint governing Treg cell homeostasis and the resolution of lung inflammation.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acsbg1; IL-33; IL-5; Treg cells; airway inflammation; fatty acid metabolism; mitochondrial fitness; pathogenic Th2 cells

Mesh:

Substances:

Year:  2021        PMID: 34758300     DOI: 10.1016/j.celrep.2021.109921

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  2 in total

Review 1.  Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology.

Authors:  Darya Malko; Tarek Elmzzahi; Marc Beyer
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

2.  SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4+ T cells.

Authors:  Toshio Kanno; Keisuke Miyako; Takahiro Nakajima; Satoru Yokoyama; Shigemi Sasamoto; Hikari K Asou; Osamu Ohara; Toshinori Nakayama; Yusuke Endo
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.